Cialis carries more weight in BPH on new Phase III data
This article was originally published in Scrip
Executive Summary
There was more good news for Lilly's Cialis franchise as a new Phase III study showed that Cialis (tadalafil), in parallel with tamsulosin (Boehringer Ingelheim's Flomax) as an active control, significantly improved prostate symptom scores in men with signs and symptoms suggestive of benign prostatic hyperplasia (BPH).